Free Trial

Aprea Therapeutics (APRE) Insider Trading & Ownership

Aprea Therapeutics logo
$3.08 -0.26 (-7.78%)
(As of 12/18/2024 05:44 PM ET)

Aprea Therapeutics (NASDAQ:APRE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.80%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$237,048.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$29,595.96
Get APRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

APRE Insider Buying and Selling by Quarter

Aprea Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/23/2024Oren GiladCEOBuy500$3.92$1,960.00  
10/18/2024Marc DueyDirectorSell6,462$4.58$29,595.96  
10/16/2024Marc DueyDirectorBuy30,000$4.39$131,700.00  
10/14/2024Marc DueyDirectorBuy190$2.58$490.20  
10/14/2024Oren GiladCEOBuy1,000$2.59$2,590.00  
10/11/2024Bernd R SeizingerDirectorBuy10,000$2.68$26,800.00  
10/10/2024John P HamillCFOBuy450$2.61$1,174.50  
10/10/2024Oren GiladCEOBuy150$2.54$381.00  
3/13/2024Bernd R SeizingerDirectorBuy6,860$7.29$50,009.40  
3/13/2024John P HamillCFOBuy1,010$7.29$7,362.90  
3/13/2024Oren GiladCEOBuy2,000$7.29$14,580.00  
(Data available from 1/1/2013 forward)

APRE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aprea Therapeutics includes Bernd R Seizinger, Eyal C Attar, John P Hamill, Marc Duey, and Oren Gilad. Learn more on insiders at APRE.

12.80% of Aprea Therapeutics stock is owned by insiders. Learn more on APRE's insider holdings.

The following insiders have purchased APRE shares in the last 24 months: Bernd R Seizinger ($91,576.24), John P Hamill ($8,537.40), Marc Duey ($132,190.20), and Oren Gilad ($19,511.00).

Insiders have purchased a total of 56,228 APRE shares in the last 24 months for a total of $251,814.84 bought.

The following insider sold APRE shares in the last 24 months: Marc Duey ($29,595.96).

Insiders have sold a total of 6,462 Aprea Therapeutics shares in the last 24 months for a total of $29,595.96 sold.

Aprea Therapeutics Key Executives

  • Dr. Oren Gilad Ph.D. (Age 56)
    Co-Founder, CEO, President & Director
    Compensation: $796.95k
  • Mr. John P. Hamill CPA (Age 60)
    Senior VP, CFO, Principal Accounting Officer & Secretary
    Compensation: $610.23k
    1 recent trades
  • Dr. Dansu Li Ph.D.
    Head of Technology
  • Dr. Lars B. Abrahmsen Ph.D. (Age 67)
    Senior VP & Chief Scientific Officer
  • Mr. Brian Wiley (Age 56)
    Senior Vice President of Corporate Development & Strategy
  • Dr. Michel Afargan Ph.D.
    Head of Pharmacology Development
  • Mr. Ze'ev Weiss B.Sc. (Age 62)
    C.P.A., Chief Business Advisor
  • Dr. Nadeem Q. Mirza M.D.
    M.P.H., Chief Medical Officer
  • Ms. Andrea Epstein
    Controller


This page (NASDAQ:APRE) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners